Home4503 • TYO
add
Astellas Pharma Inc
Nakaraang pagsara
¥1,488.50
Sakop ng araw
¥1,476.00 - ¥1,489.50
Sakop ng taon
¥1,415.00 - ¥1,835.00
Market cap
2.67T JPY
Average na Volume
6.50M
P/E ratio
-
Dividend yield
4.87%
Primary exchange
TYO
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 517.41B | 22.63% |
Gastos sa pagpapatakbo | 343.99B | 5.14% |
Net na kita | -97.66B | -772.91% |
Net profit margin | -18.87 | -648.55% |
Kita sa bawat share | — | — |
EBITDA | 126.06B | 91.43% |
Aktuwal na % ng binabayarang buwis | 17.49% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 179.86B | -29.18% |
Kabuuang asset | 3.45T | 2.46% |
Kabuuang sagutin | 1.96T | 4.95% |
Kabuuang equity | 1.49T | — |
Natitirang share | 1.79B | — |
Presyo para makapag-book | 1.78 | — |
Return on assets | 5.42% | — |
Return on capital | 7.69% | — |
Cash Flow
Net change in cash
| (JPY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -97.66B | -772.91% |
Cash mula sa mga operasyon | 16.03B | -68.83% |
Cash mula sa pag-invest | -30.72B | 23.79% |
Cash mula sa financing | -104.30B | -19.85% |
Net change in cash | -113.13B | -41.38% |
Malayang cash flow | 13.83B | -53.18% |
Tungkol
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Itinatag
Abr 1, 2005
Headquarters
Website
Mga Empleyado
14,754
